HOW THE PATHOPHYSIOLOGY OF GILBERT'S SYNDROME AFFECTS THE DAILY LIVES OF PATIENTS WITH GILBERT´'S SYNDROME: AN INTEGRATIVE REVIEW
DOI:
https://doi.org/10.47820/recima21.v5i10.5731Keywords:
Gilbert's Syndrome, UDP-glucuroniltransferase, SyndromeAbstract
Gilbert's Syndrome (SG) is configured as a hereditary pathology, in which a mutation occurs in the UGT1A1 gene, reducing the activity of the UDP-glucuroniltransferase enzyme, whose consequence is to change the levels of unconjugated bilirubin in the blood, generating hyperbilirubinemia. This excess of serum indirect bilirubin can lead to several clinical manifestations. Through the present study, it was observed that the symptoms can present both in a harmful and beneficial way. Among the harms, jaundice, epigastric pain and lack of energy stand out. On the other hand, cardiovascular protections and antioxidant effects characterize some of the benefits of this mutation. The diagnosis requires, in addition to complementary tests, an evaluation of serum levels of total bilirubin. It is noted that the exacerbated increase in indirect bilirubin is influenced by several factors, such as ethnicity, smoking, eating habits, genetics and sex. In addition, it is configured as a molecule with anti-inflammatory, antiatherogenic, antithrombotic and immunomodulatory effects, but an increased risk of developing diabetes mellitus, cervical and colon cancer is reported. SG is prevalent in males and does not require pharmacotherapeutic or dietary treatment, however a specialized follow-up should be carried out periodically.
Downloads
References
ALIARAB, Azadeh et al. Effect of gilbert's syndrome associated polymorphic alleles (rs8175347 and rs4148323) of UDP-glucuronyl transferase on serum bilirubin level. Meta Gene, v. 26, p. 100788, 2020. DOI: https://doi.org/10.1016/j.mgene.2020.100788
EREMIASOVA, Lenka et al. Serum Bilirubin in the Czech Population―Relationship to the Risk of Myocardial Infarction in Males―. Circulation Journal, v. 84, n. 10, p. 1779-1785, 2020. DOI: https://doi.org/10.1253/circj.CJ-20-0192
GU, Leilei et al. Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population. Molecular Genetics & Genomic Medicine, v. 10, n. 7, p. e1958, 2022. DOI: https://doi.org/10.1002/mgg3.1958
HANA, Claudia A. et al. Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals. Metabolism, v. 125, p. 154913, 2021. DOI: https://doi.org/10.1016/j.metabol.2021.154913
HSU, Paul Wei-Che et al. The mutation hotspots at UGT1A locus may Be associated with gilbert’s syndrome affecting the Taiwanese population. International Journal of Molecular Sciences, v. 23, n. 20, p. 12709, 2022. DOI: https://doi.org/10.3390/ijms232012709
HUANG, May‐Jen et al. Effect of UDP‐glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome. The Kaohsiung Journal of Medical Sciences, v. 35, n. 7, p. 432-439, 2019. DOI: https://doi.org/10.1002/kjm2.12077
HUANG, May‐Jen; CHEN, Pei‐Lain; HUANG, Ching‐Shan. Bilirubin metabolism and UDP‐glucuronosyltransferase 1A1 variants in Asians: Pathogenic implications and therapeutic response. The Kaohsiung Journal of Medical Sciences, v. 38, n. 8, p. 729-738, 2022. DOI: https://doi.org/10.1002/kjm2.12579
KAMAL, Sanaa et al. The frequency, clinical course, and health related quality of life in adults with Gilbert’s syndrome: a longitudinal study. BMC gastroenterology, v. 19, p. 1-14, 2019. DOI: https://doi.org/10.1186/s12876-019-0931-2
KANG, Ling-Ling; MA, Yong-Jian; ZHANG, Hou-De. Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome. Medicine, v. 99, n. 7, p. e19109, 2020. DOI: https://doi.org/10.1097/MD.0000000000019109
MI, Xiao-xiao et al. Analysis of the UGT1A1 genotype in hyperbilirubinemia patients: differences in allele frequency and distribution. BioMed Research International, v. 2019, n. 1, p. 6272174, 2019. DOI: https://doi.org/10.1155/2019/6272174
RAVINDRAN, Ravi Rajan. Jaundice. Surgery (Oxford), v. 38, n. 8, p. 446-452, 2020. DOI: https://doi.org/10.1016/j.mpsur.2020.06.008
SOOD, Vikrant et al. Gilbert’s syndrome in children with unconjugated hyperbilirubinemia–an analysis of 170 cases. The Indian Journal of Pediatrics, v. 88, p. 154-157, 2021. DOI: https://doi.org/10.1007/s12098-020-03271-6
SULTAN, Amir; KIFLU, Kibrewossen. Gilbert syndrome in a young Ethiopian man: first case report. Ethiopian Journal of Health Sciences, v. 31, n. 1, 2021. DOI: https://doi.org/10.4314/ejhs.v31i1.23
VITEK, Libor et al. The physiology of bilirubin: health and disease equilibrium. Trends in molecular medicine, v. 29, n. 4, p. 315-328, 2023. DOI: https://doi.org/10.1016/j.molmed.2023.01.007
VITEK, Libor; BELLAROSA, Cristina; TIRIBELLI, Claudio. Induction of mild hyperbilirubinemia: hype or real therapeutic opportunity?. Clinical Pharmacology & Therapeutics, v. 106, n. 3, p. 568-575, 2019. DOI: https://doi.org/10.1002/cpt.1341
VÍTEK, Libor; TIRIBELLI, Claudio. Gilbert´ s syndrome revisited. Journal of hepatology, 2023. DOI: https://doi.org/10.1016/j.jhep.2023.06.004
YAO, Miao-En et al. Physiologically increased total bilirubin is associated with reduced risk of first myocardial infarction: a meta-analysis and dose-response analysis. Nutrition, Metabolism and Cardiovascular Diseases, v. 31, n. 4, p. 1016-1026, 2021. DOI: https://doi.org/10.1016/j.numecd.2021.01.002
YAO, Qing et al. Therapeutic application and construction of bilirubin incorporated nanoparticles. Journal of Controlled Release, v. 328, p. 407-424, 2020. DOI: https://doi.org/10.1016/j.jconrel.2020.08.054
ZHANG, Meng et al. Compound heterozygous UGT1A1* 28 and UGT1A1* 6 or single homozygous UGT1A1* 28 are major genotypes associated with Gilbert’s syndrome in Chinese Han people. Gene, v. 781, p. 145526, 2021. DOI: https://doi.org/10.1016/j.gene.2021.145526
ZÖHRER, Patrick A. et al. Gilbert’s syndrome and the gut microbiota–insights from the case-control BILIHEALTH study. Frontiers in cellular and infection microbiology, v. 11, p. 701109, 2021. DOI: https://doi.org/10.3389/fcimb.2021.701109
Downloads
Published
How to Cite
License
Copyright (c) 2024 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
